|Day Low/High||47.96 / 49.12|
|52 Wk Low/High||37.62 / 51.84|
So what does a government shutdown mean for today's trading? Here's what you need to know before Monday's opening bell.
Some French companies will get a temporary windfall, but others will need to pay more tax.
Tesla and General Motors are among this week's names showing reversal patterns.
Investors keep an eye on another busy slate of earnings.
The Montrouge, France-based firm on Friday unveiled top-line results from its Phase 3 study of a peanut allergy treatment. The study, dubbed Pepites, evaluated Viaskin Peanut in children four to 11 years old.
Burlington, Mass.-based Flexion Therapeutics said Friday it has receive FDA approval for osteoarthritis knee pain treatment Zilretta, a non-opioid medicine utilizing Flexion's microsphere technology.
Shark Tank's Robert Herjavec on why the Equifax hack is different from others cyber attacks.
Sarepta CEO Ed Kaye said he's stepping down.
Sanofi SA agreed to a U.S. Department of Justice a $19.8 million fine for overcharging the U.S. Department of Veteran Affairs.
Why the name is sagging, and what it will take to spur the sector higher.
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
Hollywood's lack of originality shines through with 15 remakes and sequels this year.
There are nearly too many surging sectors to count.
SNY has become much stronger since late October; buy here and above $44.
Animal health and oncology deal activity is heating up in 2017.
After a court halts Regeneron's sales of Praluent, Jim Cramer sees opportunity in Amgen.
A federal judge has banned the sale of Regeneron's cholesterol-lowering drug Praluent, handing a surprise and overwhelming victory to Amgen and its competing drug Repatha in a long-running patent lawsuit.
Jim Cramer comments on Johnson & Johnson's move to abandon merger talks with Actelion.
As we all know, the stock market and the economy abhor uncertainty.
It was a volatile end to the week after federal investigators reopened a case into Hillary Clinton's email server.
The Chart of the Day demonstrates the widening schism between the real economy and stock prices. The issuance of negative-yielding European corporate debt by Henkel, Deutsche Bahn and Sanofi are the definition of insanity. Euro bond prices are in t...
Regular readers of my diary know that I sometimes post something that replicates the theme of the Tell Me Something I Don't Know segment on MSNBC's Hardball With Chris Matthews. So ... "Tell me something I don't know, Dougie." OK, here goes: Henkel ...